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miR-29b regulates expression 
of collagens I and III in 
chondrogenically differentiating 
BMSC in an osteoarthritic 
environment
Ute Mayer1,2, Achim Benditz2 & Susanne Grässel1,2
Osteoarthritis (OA) is characterized by a slowly progressing, irreversible loss of articular cartilage. 
Tissue engineering approaches for cartilage regeneration include stem cell-based strategies but not 
much is known about their repair capacity in an OA microenvironment. The aim of the present study 
was to identify factors regulating collagen expression during chondrogenic differentiation of bone 
marrow-derived mesenchymal stem cells (BMSC) in an OA microenvironment. Coculture with OA 
cartilage induced miR-29b expression in BMSC which inhibited collagen I and III expression. Elevated 
miR-29b expression resulted in higher caspase 3/7 activity and promoted apoptosis of BMSC in part by 
directly inhibiting the anti-apoptotic proteins Bcl-2 and Mcl-1. Stimulation with IFN-γ induced miR-29b 
expression in BMSC. Our results suggest that miR-29b affects BMSC-based OA cartilage regeneration 
because expression of collagen III, mainly produced by undifferentiated BMSC, and collagen I, a marker 
for dedifferentiated chondrocytes, are inhibited by miR-29b thus influencing composition of the newly 
formed ECM. This might be critical to avoid formation of inferior fibrocartilage instead of hyaline 
cartilage. Furthermore, higher miR-29b expression promotes apoptosis either preventing excessive 
cell growth or reducing the number of BMSC undergoing chondrogenesis. Thus, miR-29b has both 
supportive but possibly also unfavourable effects on BMSC-based OA cartilage regeneration.
Osteoarthritis (OA) is a common, multi-factorial, slowly progressing and irreversible degenerative disorder 
affecting entire synovial joints mostly of hands, knees and hips. The risk to develop OA increases with age and 
genetic predisposition, obesity, mechanical influences and traumatic joint injury are other risk factors. OA is 
characterized by loss of articular cartilage, changes in subchondral bone and variable degrees of synovial inflam-
mation which leads to pain, stiffness, limitation in motility and eventually loss of joint function1–3.
Cartilage possesses only very limited capacity for self-repair because it is a non-vascularised, aneural tis-
sue with a low density of cells which are trapped within a tight extracellular matrix4,5. Hence, regeneration of 
degraded cartilage is challenging6. Tissue engineering approaches for cartilage regeneration include cell-based 
strategies using chondrocytes or multipotent stem cells, alone or in combination with scaffolds7. Cultured 
human bone marrow-derived mesenchymal stem cells (BMSC) possess chondrogenic differentiation potential8 
but not much is known about their capacity to form cartilage under the influence of the OA microenviron-
ment if they are isolated from OA patients, expanded in vitro and then reimplanted into a diseased joint. Some 
studies reported that mesenchymal stem cells (MSC) from patients with OA showed reduced chondrogenic 
activity9 whereas others observed similar chondrogenic potential of MSC from OA patients compared to that 
of healthy donors10 and that the chondrogenic potential of adult MSC is independent of age or OA aetiology11. 
Even if autologous MSC from OA patients may be a promising cell source with chondrogenic differentiation 
potential, not much is known about the capacity of MSC for chondral or osteochondral regeneration in an OA 
environment.
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The goal of cell-based therapies in OA-pathology is to implant cells into the diseased cartilage area or lesion 
where they are supposed to form a long-lasting and functional repair tissue. However, the cellular microenvi-
ronment in a joint and their paracrine signals can profoundly influence chondrogenic differentiation of MSC12. 
There are both positive and negative effects of OA-related factors on MSC differentiation reported. On the one 
hand, soluble morphogens secreted by primary OA chondrocytes induced chondrogenic and downregulated 
hypertrophic differentiation of MSC13. On the other hand, catabolic factors present in OA joints inhibited chon-
drogenesis14. In previous studies we observed that articular cartilage and subchondral bone explants from OA 
patients affected the extracellular matrix (ECM) production and composition of cocultured BMSC15,16. In general, 
coculture with OA cartilage explants resulted in reduced collagen gene and protein expression in chondrogeni-
cally differentiating BMSC compared to monocultured cells. Collagen II accounts for up to 95% of the articular 
cartilage collagens17, whereas induction of collagen I synthesis is associated with dedifferentiating chondrocytes 
losing their chondrogenic phenotype18. Collagen I is detected in late-stage OA cartilage19 and collagen III is not 
only detected in OA cartilage20 but also in normal cartilage21. Undifferentiated BMSC secrete more collagen III 
than collagen I22. If BMSC undergo chondrogenic differentiation in coculture with OA cartilage explants, both 
collagen I and III expression become reduced compared to BMSC kept in monocultures15.
One possible mechanism for the downregulation of collagen I and III expression found in BMSC cocultured 
with OA cartilage might be via microRNAs (miR), short non-coding RNAs which regulate gene expression 
post-transcriptionally23. MiRs play a role in normal cartilage matrix development and homeostasis participating 
in the regulation of ECM production and turnover, growth factor regulation, differentiation, proliferation and 
apoptosis of chondrocytes and cartilage degeneration during OA24–26. MiRs are implicated in chondrogenesis by 
modulating expression of growth- and transcription factors and they are involved in the development of OA by 
regulating proteolytic enzymes27,28. During chondrogenic differentiation, MSC alter their miR expression profile: 
some miRs are upregulated while others are downregulated and many putative targets of these miRs are genes 
well known to be involved in chondrogenic differentiation29–32.
It is reported that SOX9, the master transcription factor of chondrogenesis, represses expression of miR-
29a-3p and miR-29b-3p via the 29a/b1 promoter whereas IL-1β increases the expression of the miR-29 family in 
primary human chondrocytes33. Among the multiple putative targets of the miR-29 family are several collagens 
as predicted by different algorithms using miRWalk2.034. Direct binding of miR-29b to the mRNA within the 
3′-UTR of COL1A1 and COL3A1 leading to mRNA degradation or preventing its translation is confirmed by 
luciferase reporter gene assays e.g. by Steele, et al.35.
In a previous study we observed that both collagen I and III expression was downregulated in BMSC under-
going chondrogenic differentiation in coculture with OA cartilage explants compared to BMSC kept in monocul-
tures15. The aim of the present study was to identify factors of the OA microenvironment which are responsible 
for the regulation of collagen I and III expression during chondrogenic differentiation of BMSC in coculture with 
OA cartilage. We hypothesized a miR-mediated regulation of collagen I and III expression. Hence, we investigated 
the influence of OA cartilage on the expression of a specific miR, miR-29b-3p, in cocultured chondrogenically 
differentiating BMSC. In addition, we analysed the effects of miR-29b-3p overexpression and inhibition on the 
expression of its targets, COL1A1 and COL3A1 and its influence on cell survival. Furthermore, BMSC were stim-
ulated with soluble factors known to be released from OA cartilage to identify a candidate molecule responsible 
for miR-29b-3p regulation.
Results
Two different 3D culture systems to induce chondrogenic differentiation of BMSC were used and some exper-
iments were performed in 2D monolayer culture as stated in the figure headings. For direct coculture with OA 
cartilage/bone, BMSC were embedded in fibrin gels and indirect coculture with medium conditioned with OA 
cartilage was performed with micromass pellets.
Soluble OA cartilage derived factors promote miR-29b expression in cocultured BMSC and 
repress COL1A1 and COL3A1 gene expression and protein secretion. BMSC embedded in fibrin 
gels subjected to chondrogenic differentiation on top of OA cartilage explants for 7 and 28 days, exhibited lower 
COL1A1 and COL3A1 and higher gene expression levels of mature miR-29b-3p compared to BMSC kept in 
monoculture without cartilage explants (Fig. 1a). COL2A1 gene expression was significantly lower in cocultured 
BMSC compared to monocultures at day 7. OA subchondral bone explants had no significant effect on miR-29b, 
COL1A1, COL3A1 and COL2A1 gene expression of cocultured BMSC subjected to chondrogenic differentiation 
after 7 and 28 days compared to monocultured cells (Fig. 1b). In both, BMSC kept in monoculture and coculture 
with OA cartilage COL2A1 gene expression increased from day 7 to day 28 indicating chondrogenic differenti-
ation whereas no significant change in COL2A1 expression of BMSC in coculture with OA subchondral bone 
occurred at day 28 compared to day 7. Notably, miR-29b, COL1A1 and COL3A1 gene expression remained unal-
tered in all culture conditions until 28 days compared to day 7 (Fig. 1c).
As Le et al. observed an inverse correlation of miR-29 and SOX9 gene expression during chondrogenesis of 
MSC and showed that Sox9 overexpression repressed expression of miR-29 family members, whilst knockdown 
of Sox9 increased their expression33, we analysed SOX9 gene expression level of BMSC cocultured with OA carti-
lage and bone. After 7 and 28 days of chondrogenic differentiation of BMSC embedded in fibrin gels and cultured 
on top of OA cartilage- and bone explants we did not detect changes in SOX9 expression (Fig. 1d). Compared to 
day 7, SOX9 gene expression remained unaltered in BMSC in monoculture and in coculture with OA cartilage 
and bone explants until the end of culture at 28 days (Fig. 1e).
To determine if the upregulation of miR-29b gene expression and concomitant downregulation of COL1A1 
and COL3A1 gene expression in BMSC cocultured with OA cartilage is mediated through soluble factors 
derived from OA cartilage or if a direct cellular contact to OA cartilage is required, we used conditioned culture 
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Figure 1. MiR-29b, COL1A1, COL2A1, COL3A1 and SOX9 gene expression of BMSC cocultured with OA 
cartilage and OA bone explants. (a) miR-29b (white bars), COL1A1 (light grey bars), COL3A1 (dark grey 
bars) and COL2A1 (black bars) gene expression of BMSC embedded in fibrin gels and cocultured on OA 
cartilage explants for 7 days (bars without pattern) and 28 days (bars with pattern) compared to corresponding 
monocultures (zero line, n = 8). (b) miR-29b (white bars), COL1A1 (light grey bars), COL3A1 (dark grey 
bars) and COL2A1 (black bars) gene expression of BMSC embedded in fibrin gels and cocultured on OA 
bone explants for 7 days (bars without pattern) and 28 days (bars with pattern) compared to corresponding 
monocultures (zero line, n = 6). (c) miR-29b (white bars), COL1A1 (light grey bars), COL3A1 (dark grey bars) 
and COL2A1 (black bars) gene expression of BMSC embedded in fibrin gels in monoculture (bars without 
pattern), in coculture with OA cartilage explants (dotted bars) and in coculture with OA bone explants (hatched 
bars) at day 28 compared to day 7 (zero line, n = 6–8). (d) SOX9 gene expression of BMSC embedded in fibrin 
gels and cocultured on OA cartilage (light grey bars) and OA bone explants (dark grey bars) for 7 days (bars 
without pattern) and 28 days (bars with pattern) compared to corresponding monocultures (zero line; n = 6). 
(e) SOX9 gene expression of BMSC embedded in fibrin gels in monoculture (white bar), in coculture with OA 
cartilage explants (light grey bar) and in coculture with OA bone explants (dark grey bar) at day 28 compared 
to day 7 (zero line, n = 6). Results are expressed as box plots with median, the 25th and 75th percentiles and 
whiskers showing the largest and smallest values. * = p < 0.05; ** = p < 0.01; non-parametric Wilcoxon signed 
rank test for paired analysis.
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supernatant from cell-free OA cartilage explants. For that, expression levels of COL1A1, COL3A1, COL2A1 and 
miR-29b of BMSC kept in micromass pellets cultured for 7 days in chondrogenic medium conditioned with OA 
cartilage (conditioned medium = CM) were compared to BMSC micromass pellets cultured in non-conditioned 
chondrogenic medium (non-conditioned medium = NM). BMSC cultured in CM expressed significantly more 
miR-29b and less COL1A1 and COL3A1 mRNA than BMSC cultured in NM while COL2A1 expression was not 
significantly changed by CM (Fig. 2a). BMSC cultured in CM secreted approximately 50% less collagen I into 
culture supernatants than BMSC cultured in NM while secretion of collagen III -which could hardly be detected- 
was not influenced by CM after 7 days (Fig. 2b,c). Collagen II was not detected in supernatants of BMSC micro-
mass pellets after 7 days of chondrogenic induction (data not shown).
miR-29b regulates COL1A1 and COL3A1 mRNA and corresponding protein synthesis. To verify 
if the elevated miR-29b gene expression levels detected in BMSC cocultured with OA cartilage explants or cul-
tured in OA cartilage CM are responsible for the reduced COL1A1 and COL3A1 gene expression, miR-29b was 
overexpressed in BMSC by transfection with a miR-29b mimic, a small, chemically modified double-stranded 
RNA that mimics the endogenous miR. After transfection, elevated miR-29b levels and accordingly reduced 
COL1A1 and COL3A1 gene expression (Fig. 3a) and corresponding protein synthesis (Fig. 3b) was detected in 
comparison to that of BMSC transfected with a non-targeting control miR (NT-miR). COL2A1 gene and protein 
expression was not detectable in these miR-29b mimic transfected BMSC kept in chondrogenic medium for 2 
days. To further confirm that higher miR-29b levels contribute to the reduction of COL1A1 and COL3A1 gene 
expression in BMSC cocultured with OA cartilage or cultured in OA cartilage CM, BMSC were transfected with 
NT-miR or miR-29b inhibitor. Latter is a small, chemically modified single-stranded RNA molecule designed 
Figure 2. Gene expression and protein secretion of BMSC cultured in medium conditioned with OA cartilage. 
(a) miR-29b (white bar), COL1A1 (light grey bar), COL3A1 (dark grey bar) and COL2A1 (black bar) gene 
expression of BMSC kept in micromass pellets and cultured for 7 days in chondrogenic medium conditioned 
with OA cartilage (CM) compared to non-conditioned chondrogenic medium (NM, zero line, n = 7). (b) 
Densitometric quantification of alpha1 and alpha2 chains of collagen I (light grey bar) and III (dark grey bar) 
western blot images of collagen extracts from cell culture supernatants of BMSC kept in micromass pellets for 
7 days in CM relative to NM (line at 100%, n = 6). (c) Representative collagen I and III western blot images 
from collagen extracts of cell culture supernatants of BMSC kept in micromass pellets for 7 days in NM and 
CM (n = 6). Full-length blots are presented in Supplementary Figure S1. Results are expressed as box plots with 
median, the 25th and 75th percentiles and whiskers showing the largest and smallest values. * = p < 0.05; non-
parametric Wilcoxon signed rank test for paired analysis. CM: with OA cartilage conditioned medium; NM: 
non-conditioned medium.
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to specifically bind to and inhibit endogenous miR-29b molecules leading to downregulation of miR activity by 
preventing the binding of the miR to its target mRNA. The miR-29b inhibitor had no significant influence on 
collagen expression of BMSC in monolayer culture 72 h after transfection (data not shown) presumably because 
the impact of inhibiting basal miR-29b levels was too weak to show a detectable effect on collagen protein levels. 
Therefore, we switched from monolayer to micromass pellet culture kept in CM because that culture regimen 
resulted in upregulation of miR-29b whose activity could be subsequently blocked by the miR-29b inhibitor. 
After transfection, BMSC were cultivated as micromass pellets for 7 days in chondrogenic CM. MiR-29b inhibitor 
transfected BMSC exhibited significantly lower miR-29b and higher COL1A1 and COL3A1 gene expression levels 
compared to BMSC transfected with NT-miR while COL2A1 gene expression remained unaltered. In NT-miR 
transfected BMSC the increased miR-29b expression levels, induced by culture in CM, are not blocked (Fig. 3c).
miR-29b promotes apoptosis of BMSC. Additionally to its inhibitory effect on collagen expression, miR-
29b modulated cell survival. BMSC cultured in CM showed higher caspase 3/7 activity which correlates with 
increased apoptotic activity compared to that of BMSC in NM (Fig. 4a). Likewise, miR-29b overexpression by 
transfection of BMSC with miR-29b mimic resulted in higher caspase 3/7 activity compared to BMSC transfected 
with NT-miR (Fig. 4b). Verifying the contribution of elevated miR-29b expression induced by CM, caspase 3/7 
activity in BMSC transfected either with a miR-29b inhibitor or NT-miR and subsequently cultured in CM, was 
measured. Blocking the activity of miR-29b with the inhibitor significantly reduced caspase 3/7 activity compared 
to BMSC transfected with a NT-miR (Fig. 4c).
A possible mechanism how miR-29b influences caspase 3/7 activity is by modulating expression of regulators 
of apoptosis like the anti-apoptotic proteins Bcl-2 and Mcl-1, both known targets of the miR-29 family. Culture 
in CM leads to significantly lower BCL2 expression in comparison to that of BMSC cultured in NM while MCL1 
expression is unaltered (Fig. 5a). Overexpression of miR-29b by transfection with miR-29b mimic resulted in 
higher miR-29b level and both BCL2 and MCL1 gene expression reduction (Fig. 5b). Transfection with a miR-29b 
Figure 3. Gene and protein expression of collagens I and III in BMSC transfected with miR-29b mimic and 
inhibitor. (a) miR-29b (white bar), COL1A1 (light grey bar) and COL3A1 (dark grey bar) gene expression of 
BMSC in monolayer transfected with miR-29b mimic compared to BMSC transfected with a non-targeting 
control miR (NT-miR, zero line, n = 6). (b) Representative collagen I (n = 6) and III (n = 3) western blot 
images of total protein lysates of BMSC in monolayer transfected with mimic and NT-miR and corresponding 
β-Actin blots as loading controls. (c) miR-29b (white bar), COL1A1 (light grey bar), COL3A1 (dark grey 
bar) and COL2A1 (black bar) gene expression of BMSC transfected in monolayer with miR-29b inhibitor 
and subsequently cultured in micromass pellets for 7 days in chondrogenic medium conditioned with OA 
cartilage (CM) compared to BMSC transfected with NT-miR and cultured in CM (NT-miR + CM, zero line, 
n = 8). Results are expressed as box plots with median, the 25th and 75th percentiles and whiskers showing the 
largest and smallest values. * = p < 0.05; ** = p < 0.01; non-parametric Wilcoxon signed rank test for paired 
analysis. mimic: miR-29b mimic; NT-miR: non-targeting control miR; inhibitor + CM: with miR-29b inhibitor 
transfected BMSC cultured in medium conditioned with OA cartilage; NT-miR + CM: with non-targeting 
control miR transfected BMSC cultured in medium conditioned with OA cartilage.
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inhibitor decreased miR-29b level and increased MCL1 gene expression significantly while BCL2 gene expression 
remains unaltered compared to the level of expression in BMSC transfected with NT-miR and cultured in CM 
(Fig. 5c).
miR-29b does not modulate proliferation of BMSC. BMSC cultured in CM have significantly more 
BrdU incorporated during DNA synthesis indicating higher proliferation rates compared to BMSC in NM 
(Supplementary Figure S2a). However, miR-29b overexpression by transfection of BMSC with miR-29b mimic 
resulted in unchanged BrdU incorporation levels compared to BMSC transfected with a NT-miR (Supplementary 
Figure S2b).
Stimulation with IFN-γ induces miR-29b expression. As soluble factors derived from OA cartilage 
are responsible for the upregulation of miR-29b expression we tested if the upregulation of miR-29b could be pre-
vented by blocking the activity of proteases in CM using protease inhibitors. Additionally to serine and cysteine 
proteases, the applied inhibitor cocktail containing EDTA inhibits also matrix metalloproteases (MMPs). Both 
protease inhibitor cocktails (+EDTA; Fig. 6a and - EDTA; Fig. 6b) did not prevent the upregulation of miR-29b 
and downregulation of COL1A1 and COL3A1 gene expression in BMSC cultured in CM compared to BMSC kept 
in NM.
Supernatants of BMSC in coculture with OA cartilage contain higher concentrations of pro-inflammatory 
cytokines like IL-1β, IL-6 and IL-8 than BMSC kept in monoculture15. These factors can have an inhibitory effect 
on collagen gene expression and synthesis in BMSC. As miR-29b expression is induced by soluble factors derived 
from OA cartilage, we investigated the potential of IL-1β, IL-6 and IL-8 to stimulate the expression of miR-29b. 
Stimulation of BMSC cultured as micromass pellets in chondrogenic medium with IL-1β caused no upregulation 
of miR-29b however, significantly reduced both COL1A1 and COL2A1 but significantly increased COL3A1 gene 
expression compared to unstimulated BMSC (Fig. 7a). Stimulation with IL-6 or IL-8 did not regulate gene expres-
sion of miR-29b, COL1A1, COL3A1 and COL2A1 (Fig. 7b,c). Additionally, stimulation with LIF and TNF-α had 
Figure 4. Quantification of caspase 3/7 activity in BMSC. (a) Caspase 3/7 activity of BMSC in monolayer 
cultured in chondrogenic medium conditioned with OA cartilage (CM) relative to non-conditioned medium 
(NM, line at 100%, n = 8). (b) Caspase 3/7 activity of BMSC in monolayer transfected with miR-29b mimic 
relative to BMSC transfected with a non-targeting control miR (NT-miR, line at 100%, n = 8). (c) Caspase 3/7 
activity of BMSC in monolayer transfected with miR-29b inhibitor and subsequently cultured in CM relative 
to BMSC transfected with NT-miR and cultured in CM (NT-miR + CM, line at 100%, n = 10). Results are 
expressed as box plots with median, the 25th and 75th percentiles and whiskers showing the largest and smallest 
values. * = p < 0.05; ** = p < 0.01; non-parametric Wilcoxon signed rank test for paired analysis. CM: with OA 
cartilage conditioned medium; NM: non-conditioned medium; mimic: miR-29b mimic; NT-miR: non-targeting 
control miR; inhibitor + CM: with miR-29b inhibitor transfected BMSC cultured in medium conditioned 
with OA cartilage; NT-miR + CM: with non-targeting control miR transfected BMSC cultured in medium 
conditioned with OA cartilage.
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also no effect on miR-29b expression (data not shown), but stimulation with IFN-γ led to significant upregula-
tion of miR-29b and downregulation of COL1A1 and COL3A1 gene expression (Fig. 7d). IFN-γ downregulated 
COL2A1gene expression profoundly resulting in only 4 out of 11 samples with acceptable CT values in qPCR 
analysis. Titration with increasing concentrations of IFN-γ provoked increasing upregulation of miR-29b and 
increasing downregulation of COL1A1, COL3A1 and COL2A1 gene expression (Supplementary Figure S3).
Statistical data from all experiments (all figures including supplementary figures) are listed in Supplementary 
Table S5.
Discussion
To develop MSC-based cartilage repair strategies for OA treatment, signals from the diseased microenvironment 
at the site of cell implantation need to be considered which affect transplanted cells’ ability to survive, to undergo 
chondrogenic differentiation and to maintain the stable phenotype of mature articular chondrocytes. We have 
previously demonstrated that OA cartilage influences chondrogenic differentiation of BMSC and composition of 
newly formed matrix in vitro, however without determining specific responsible factors15.
MiRs play a crucial role in RNA silencing and post-transcriptional regulation of gene expression in many 
different biological processes including differentiation in order to modulate and maintain normal physiologi-
cal conditions. Different cell types and tissues express distinct sets of miRs which critically change during tis-
sue differentiation or pathogenesis of diseases like OA. Several studies identified miRs which were differentially 
expressed between undifferentiated and chondrogenically differentiated MSC. Han et al. detected 4 miRs (miR-
130b, -152, -26b, -28) which were upregulated in differentiated human BMSC compared to undifferentiated 
BMSC31. In human adipose-derived stem cells expression of miR-490-5p was gradually downregulated following 
induction of chondrogenic differentiation36. Complex regulatory miR networks are also involved in pathogen-
esis and progression of OA. MiR profiling of patient-derived osteoarthritic articular cartilage/chondrocytes in 
Figure 5. Expression of genes related to apoptosis in BMSC. (a) miR-29b (white bar), BCL2 (light grey bar) 
and MCL1 (dark grey bar) gene expression of BMSC kept in micromass pellets and cultured for 7 days in 
chondrogenic medium conditioned with OA cartilage (CM) compared to non-conditioned chondrogenic 
medium (NM, zero line, n = 7). (b) miR-29b (white bar), BCL2 (light grey bar) and MCL1 (dark grey bar) gene 
expression of BMSC in monolayer transfected with miR-29b mimic compared to BMSC transfected with a 
non-targeting control miR (NT-miR, zero line, n = 6). (c) miR-29b (white bar), BCL2 (light grey bar) and MCL1 
(dark grey bar) gene expression of BMSC transfected in monolayer with miR-29b inhibitor and subsequently 
kept in micromass pellets and cultured for 7 days in CM compared to BMSC transfected with NT-miR and 
cultured in CM (NT-miR + CM, zero line, n = 8). Results are expressed as box plots with median, the 25th 
and 75th percentiles and whiskers showing the largest and smallest values. * = p < 0.05; ** = p < 0.01; non-
parametric Wilcoxon signed rank test for paired analysis. CM: with OA cartilage conditioned medium; NM: 
non-conditioned medium; mimic: miR-29b mimic; NT-miR: non-targeting control miR; inhibitor + CM: with 
miR-29b inhibitor transfected BMSC cultured in medium conditioned with OA cartilage; NT-miR + CM: with 
non-targeting control miR transfected BMSC cultured in medium conditioned with OA cartilage.
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comparison to normal cartilage/chondrocytes revealed several differentially expressed miRs. For example, miR-
576-5p was downregulated and miR-483-5p was upregulated in OA chondrocytes compared to normal chondro-
cytes37. Iliopoulos et al. identified 16 miRs differentially expressed in OA- compared to normal articular cartilage 
(upregulated miRs: miR-483, -22, -377, -103, -16, -223, -30b, -23b, -509; downregulated miRs: miR-29a, -140, -25, 
-337, -210, -26a, -373)38.
Figure 6. Gene expression of BMSC cultured in conditioned medium supplemented with protease inhibitors. 
miR-29b (white bars), COL1A1 (light grey bars) and COL3A1 (dark grey bars) gene expression of BMSC 
kept in micromass pellets and cultured for 7 days in chondrogenic medium conditioned with OA cartilage 
(CM) and supplemented with protease inhibitor cocktail including EDTA which additionally inhibits matrix 
metalloproteases (a) or without EDTA (b) compared to non-conditioned chondrogenic medium (NM, zero 
line, n = 7). Results are expressed as box plots with median, the 25th and 75th percentiles and whiskers showing 
the largest and smallest values. * = p < 0.05; non-parametric Wilcoxon signed rank test for paired analysis. CM: 
with OA cartilage conditioned medium; NM: non-conditioned medium.
Figure 7. Gene expression of BMSC stimulated with different cytokines. miR-29b (white bars), COL1A1 (light 
grey bars), COL3A1 (dark grey bars) and COL2A1 (black bars) gene expression of BMSC kept in micromass 
pellets and stimulated with (a) IL-1β (1 ng/ml; n = 8), (b) IL-6 (5 ng/ml; n = 6), (c) IL-8 (10 ng/ml; n = 4) and 
(d) IFN-γ (50 ng/ml; n = 11) for 7 days compared to unstimulated controls (zero line). COL2A1 expression 
was only detected in 4 out of 11 cultures stimulated with 50 ng/ml IFN-γ. Results are expressed as box plots 
with median, the 25th and 75th percentiles and whiskers showing the largest and smallest values. * = p < 0.05; 
** = p < 0.01; *** = p < 0.001; non-parametric Wilcoxon signed rank test for paired analysis.
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Our present study indicated for the first time a role for miR-29b in regulating collagen expression during 
chondrogenic differentiation of BMSC in the presence of OA cartilage. In BMSC cocultured with OA cartilage 
explants or cultured in medium conditioned by OA cartilage, expression of miR-29b-3p was significantly higher 
whereas COL1A1 and COL3A1 expression was significantly lower compared to BMSC kept in monoculture. 
Gain- and loss-of-function experiments with miR-29b mimic and inhibitor confirmed that higher miR-29b level 
caused lower COL1A1 and COL3A1 gene expression in BMSC. In BMSC transfected with a miR-29b inhibitor, we 
detected higher COL1A1 and COL3A1 expression level when cultivated in chondrogenic medium conditioned by 
OA cartilage compared to BMSC transfected with a non-targeting control miR. We concluded that soluble factors 
released by OA cartilage caused elevated miR-29b expression level leading to reduced collagen I and III levels 
without compromising collagen II.
Besides its inhibitory effect on collagen expression, miR-29b seems also play a role in cell survival and cell 
growth. MiR-29 family members affect proliferation and apoptosis of several different cell types. Of note, miR-29 
promotes apoptosis by targeting the mRNA of anti-apoptotic proteins like Mcl-1 and Bcl-239,40 and also inhib-
its proliferation41,42. Apoptosis is affected by regulating the expression of pro- or anti-apoptotic proteins of the 
Bcl-2 family. It was reported that miR-29b directly binds to the 3′-UTR of Mcl-1 and Bcl-239. Both anti-apoptotic 
proteins are located in the outer mitochondria membrane which promotes cellular survival by inhibiting pore 
formation of pro-apoptotic proteins like Bax and Bak and thus preventing permeabilisation of the mitochondria 
membrane and cytochrome C release. Culturing BMSC in medium conditioned with OA cartilage led to higher 
miR-29b expression and reduced BCL2 expression whereas MCL1 gene expression level are equivalent to those 
of BMSC cultured in non-conditioned medium. However, overexpression of miR-29b by mimic transfection 
reduced both BCL2 and MCL1 expression significantly. Transfection of BMSC with a miR-29b inhibitor and sub-
sequent culture in conditioned medium rescued MCL1 gene expression. We thus conclude that higher miR-29b 
level induced by factors released from OA cartilage promotes apoptosis of BMSC indicated by higher caspase-3/7 
activity in part by directly inhibiting the expression of regulators of apoptosis like the anti-apoptotic proteins 
Bcl-2 and Mcl-1. As Chen et al. reported, miR-29b can promote apoptosis of rat chondrocytes also by target-
ing progranulin leading to a changed ratio of Bcl2 to Bax and an increased protein level of cleaved caspase-343. 
Contrary, miR-29b is not involved in regulation of proliferation of BMSC cultured with OA cartilage conditioned 
medium which was induced by soluble OA cartilage factors.
Next, we set out to identify factors which are responsible for the upregulation of miR-29b expression in BMSC 
during chondrogenic differentiation. Using medium conditioned by OA cartilage indicated that soluble factors 
released from OA cartilage explants are mainly responsible for the upregulation of miR-29b expression. Different 
mechanisms are known to regulate the expression of miRs which affect either their biosynthesis/maturation or 
their activity44,45. The biosynthesis of miR genes is regulated at multiple levels: pre-transcriptional by epigenetic 
control through DNA methylation46 or histone modifications47, at transcriptional level by transcription factors48, 
during processing of the primary miR transcript to the mature miR44 and post-transcriptional by RNA methyla-
tion, uridylation or adenylation45. Also, the activity of miRs is regulated by multiple factors affecting Argonaute 
loading or RISC formation with other proteins, and finally its turnover or degradation is controlled by nucleases49.
Not much is known about specific factors or mechanisms regulating miR-29b biosynthesis. In humans, two 
genes are described (MIR29B1 on chromosome 7 and MIR29B2 on chromosome 1) encoding two precursors 
(miR-29b-1 and miR-29b-2) which are spliced to mature miR-29bs of identical sequences50. The promoter regions 
of these genes contain different binding sites for several transcription factors like c-Myc or NF-κB which suppress 
expression of miR-29b51.
Le et al. observed that SOX9 expression increased up to 7 days and decreased after 14 days. This pattern was 
inversely correlated with miR-29 expression in their MSC differentiation system to form cartilage discs meaning 
that overexpression of Sox9 in chondrosarcoma cells leads to a decrease in expression of the miR-29 family, whilst 
knockdown of Sox9 increased the expression33. As we did not detect changes in SOX9 gene expression in BMSC 
in our culture system, we excluded Sox9 dependent regulation of miR-29b expression.
Factors related to inflammatory conditions are strong candidates for regulation of miR-29b synthesis as 
Le et al. reported that IL-1β increased the expression of miR-29b in chondrocytes33. In our previous study we 
observed that supernatants of BMSC cocultured with OA cartilage explants contained significantly higher IL-1β, 
IL-6 and IL-8 levels compared to monocultured BMSC15. However, stimulation of monocultured BMSC kept in 
micromass pellet with IL-1β, IL-6 and IL-8 did not induce upregulation of miR-29b. Also, stimulation with LIF, a 
member of the IL-6 family, which increased the expression of miR-29c via the JAK/STAT-3 pathway in rat kidney 
fibroblasts52 did not affect miR-29b expression in our culture regimen.
It is described that the miR-29a/b-1 promoter region contains several GAS-elements (IFN-γ acti-
vated sequences)53,54. IFN-γ activates the JAK/STAT pathway allowing activated STAT-1 dimers to bind to 
GAS-elements subsequently enhancing the expression of miR-29b in various melanoma cell lines54. Moreover, 
Tsuchida et al. detected IFN-γ in synovial fluid of OA patients but not in OA cartilage tissue extracts although OA 
chondrocytes produced IFN-γ55. In our experiments, IFN-γ stimulation significantly induced miR-29b expres-
sion and reduced COL1A1 and COL3A1 expression in a dose dependent manner compared to unstimulated 
BMSC indicating that IFN-γ is a critical regulator of miR-29b in BMSC during early chondrogenic differentiation.
In the present study, we characterized a critical role of miR-29b during chondrogenic differentiation of BMSC 
in an OA microenvironment. BMSC are able to undergo chondrogenic differentiation in our culture regimen 
indicated by increasing collagen II expression from day 7 to day 28 which seems to be not regulated via miR-29b. 
We suggest that miR-29b affects BMSC-based cartilage regeneration in an OA environment because the expres-
sion of collagen III, mainly expressed by undifferentiated MSC, and collagen I, a marker for dedifferentiated 
chondrocytes, are both inhibited by miR-29b which critically changes the composition of the newly formed ECM. 
In addition, higher miR-29b expression levels which have no influence on proliferation but promote apoptosis of 
BMSC might be considered as a control step preventing unfavourable excessive cell growth but might also have 
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a negative effect if enhancing apoptosis of mature chondrocytes as described by Chen et al.43. A strong candi-
date for miR-29b regulation is IFN-γ, a factor produced by OA chondrocytes and detected in trauma cartilage 
extracts and synovial fluid of OA patients and healthy controls55. Without doubt, it is very likely that miR-29b 
expression in vivo is not induced by one single factor but by synergy of multiple factors. In that line, Roggli et al. 
demonstrated that stimulation with a mixture of different proinflammatory cytokines increased the expression of 
miR-29b in human pancreatic islet cells56.
We conclude that high miR-29b expression during chondrogenic differentiation of BMSC in an OA microen-
vironment has both supportive and possibly also unfavourable effects on BMSC-based OA cartilage regeneration. 
High miR-29b expression promotes apoptosis preventing excessive cell growth however also reducing the number 
of BMSC undergoing chondrogenesis. Furthermore, elevated miR-29b expression induced by OA cartilage inhib-
its the expression of collagen I and III without altering collagen II expression and thus alters the composition of 
newly formed ECM which might be critical to avoid formation of inferior fibrocartilage.
Materials and Methods
Ethical statement. Collection of human material was approved by the local ethics committee (Az: 14-101-
0189; Ethikkommission, Universität Regensburg, email: ethikkommission@klinik.ukr.de) and with patients’ writ-
ten informed consent. All experiments were performed in accordance with relevant guidelines and regulations. 
This manuscript does not contain information or images that could lead to identification of the tissue donors and 
for that I do not need any further personal consent.
Isolation and culture of human BMSC, articular cartilage and subchondral bone explants. MSC 
were isolated from bone marrow which was flushed out of post-surgery discarded femoral heads of OA patients 
undergoing total hip replacement surgery and from pelvic bone material which accumulates when preparing the 
acetabulum for inserting the cup prosthesis. Bone marrow cells were separated by density gradient centrifugation 
according to established protocols15,16 and BMSC were expanded for three passages in StemMACS Expansion 
Medium (Miltenyi Biotec, Bergisch Gladbach, Germany). Due to low numbers of BMSC in the initial culture, 
cumulative population doubling level (CPDL) were counted after the P0 cell harvest. At each passage, BMSC were 
counted using a Cedex counter (Roche) and CPDL was determined by the following formula: CPDL = X + 3.322 
(log NH – log NS) where X is the PDL of the previous passage, NH is the number of harvested cells and NS is the 
number of seeded cells. The mean CPDL of BMSC after three passages was 5.66 ± 1.27 (n = 16) and the average 
time in expansion culture was 20.31 ± 2.18 days. This results in a mean proliferation rate of 0.28 ± 0.07 popula-
tion doublings per day whereby the proliferation rate decreases from each passage to the next (Supplementary 
Figure S4). In total, BMSC from 39 different donors (mean age: 67.3 ± 9.1 years, range: 47–91 years, female: 68%) 
were used.
Human subchondral bone samples with articular cartilage were obtained from knee joints of OA patients 
undergoing total knee replacement surgery. Cartilage tissue was classified macroscopically as described previ-
ously15,57 and pieces of rather intact appearing cartilage regions were cut off from the subchondral bone. Round 
cartilage explants with a diameter of 8 mm were punched out with a biopsy punch (Stiefel, GlaxoSmithKline, 
Slough, UK). Any remaining cartilage was completely removed from subchondral bone which was cut into 
approximately 5 × 5 mm squares. Articular cartilage and subchondral bone explants were used for direct cocul-
ture experiments or for generation of conditioned medium. In total, cartilage from 40 different donors (mean age: 
64.8 ± 8.0 years, range: 50–82 years, female: 55%) with similar OA grade and subchondral bone from 6 different 
donors (mean age: 61.8 ± 4.3 years, range: 57–68 years, female: 50%) were used.
3D coculture models: fibrin gels and micromass pellets. To investigate the influence of OA cartilage 
and bone on expression of collagen I, II, III and miR-29b in BMSC two different 3D coculture setups were used. 
For direct coculture, a previously described in vitro model was used15,16. Briefly, 1 × 106 BMSC were resuspended 
in fibrinogen (100 mg/ml, Sigma-Aldrich, Steinheim, Germany), mixed with thrombin (5 U/ml, Baxter, Munich, 
Germany) and placed either on the surface of articular cartilage or subchondral bone explants (coculture) and 
as a droplet on the bottom of a 24-well plate (monoculture). After polymerization for 45 min at 37 °C, chon-
drogenic medium was added consisting of high glucose DMEM (Gibco, Thermo Fisher Scientific, Rochester, 
NY, USA) supplemented with 1% Antibiotic Antimycotic Solution, 0.1 µM dexamethasone, 40 µg/ml L-proline, 
110 µg/ml sodium pyruvate, 50 µg/ml L-ascorbic acid 2-phosphate (all from Sigma-Aldrich), 1% ITS+-Premix 
(BD Biosciences, San Jose, CA, USA) and 10 ng/ml TGF-β3 (R&D Systems, Minneapolis, MN, USA). After 7 and 
28 days, cells containing fibrin gels were scraped off the cartilage and bone explant surfaces (coculture) or off the 
well bottoms (monoculture) and used for RNA isolation. 6–8 independent BMSC and cartilage/bone donors were 
used (n = 6–8).
For indirect coculture, 2 × 105 BMSC were centrifuged at 200 g for 5 min to a dense cell pellet in 96-well plates 
with conical bottoms (Nunc, Thermo Fisher Scientific). This micromass pellets were cultured in non-conditioned 
chondrogenic medium (NM) or in chondrogenic medium which was conditioned with one OA cartilage explant 
for 2 days (CM). After 7 days, 3 pellets were pooled for RNA isolation and pooled culture supernatants of 3 pellets 
were used for collagen isolation. Experiments with 7 different donors were analysed (n = 7).
Overexpression and inhibition of miR-29b. 6.5 × 104 BMSC cultured in monolayer in 6-well plates were 
transiently transfected with 50 nM mirVana miRNA mimic of hsa-miR-29b-3p (mimic), mirVana miRNA Mimic 
Negative Control #1 (NT-miR), mirVana miRNA inhibitor of hsa-miR-29b-3p (inhibitor) or mirVana miRNA 
Inhibitor Negative Control #1 (NT-miR) (all from Ambion, Thermo Fisher Scientific) using Lipofectamine 
RNAiMAX Reagent (Invitrogen, Thermo Fisher Scientific) in Opti-MEM I Reduced Serum Medium (Gibco, 
Thermo Fisher Scientific).
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Cells transfected with mimic/NT-miR were harvested after 48 h for RNA isolation and after 72 h for pro-
tein extraction. BMSC of 6 different donors were used (n = 6). BMSC transfected with inhibitor/NT-miR were 
trypsinised 24 h post-transfection, centrifuged to micromass pellets and cultured in CM for 7 days before RNA 
was isolated. This experiment was performed with BMSC from 8 different donors (n = 8).
RNA isolation and gene expression analysis. Total RNA including the miRNA fraction was iso-
lated with the MasterPure Complete RNA Purification Kit (Epicentre, Madison, WI, USA) according to 
the manufacturer’s protocol for tissue samples. RNA concentration was measured with the NanoDrop 2000 
Spectrophotometer (Thermo Fisher Scientific) and RNA quality was analysed with the Agilent 2100 Bioanalyzer 
(Agilent Technologies, Santa Clara, CA, USA). For target gene expression analysis, 400 ng RNA was reversely 
transcribed into cDNA with the AffinityScript QPCR cDNA Synthesis Kit (Agilent Technologies). Quantitative 
real-time polymerase chain reaction (qPCR) was performed in duplicates using 20–50 ng cDNA, 200 nM 
self-designed primer according to Table 1 (Microsynth, Balgach, Switzerland) and Brilliant II SYBR Green QPCR 
Master Mix (Agilent Technologies) on Mx3005 P QPCR System (Agilent Technologies). For miR-29b expres-
sion analysis, 10 ng of total RNA was reversely transcribed with the TaqMan MicroRNA Reverse Transcription 
Kit using RT primers of TaqMan MicroRNA Assays for hsa-miR-29b-3p and U6 snRNA (Applied Biosystems, 
Foster City, CA, USA). qPCR was performed in duplicates using 1.33 µl of the appropriate cDNA, TM prim-
ers of TaqMan MicroRNA Assays and TaqMan Universal PCR Master Mix II, No AmpErase UNG (Applied 
Biosystems). Quantification of gene expression was performed according to the 2−ΔΔCT-method with normali-
zation to GAPDH or U6. Expression levels are expressed as log2-fold changes relative to correspondent controls.
Protein extraction and Western Blotting. Transfected BMSC were lysed with Pierce RIPA buffer 
(Thermo Fisher Scientific) supplemented with Complete Mini Protease Inhibitor Cocktail (Roche Diagnostics, 
Mannheim, Germany) and sonicated three times (20 s, 5 cycles, 50% amplitude; SONOPULS Ultrasonic homog-
enizer, Bandelin, Berlin, Germany). Protein concentrations of these cell lysates and of cell culture supernatants 
obtained from BMSC kept as micromass pellets cultured in CM/NM were determined with Pierce BCA Protein 
Assay Kit (Thermo Fisher Scientific). Appropriate volumes of cell culture supernatants containing 1–5 mg total 
protein were digested with pepsin (5 mg/ml in 0.5 M acetic acid, 0.2 M NaCl; 100 µl/ml supernatant) for 48 h at 
4 °C with rotation. Lysates were neutralized to pH 7.0 with 1 M Tris and pepsin-resistant fibrillar collagens were 
extracted by adding NaCl to a final concentration of 4.5 M and rotating overnight at 4 °C. Pelleted proteins were 
resuspended in precipitation buffer (0.1 M Tris, 0.4 M NaCl, pH 7.4) and collagens were precipitated with ethanol 
at −20 °C overnight, centrifuged and air-dried collagen containing pellets were resuspended in Laemmli buffer 
and denatured for 10 min at 95 °C. Denatured total protein from cell lysates (20 µg for collagen I detection, 40 µg 
for collagen III detection) and collagen lysates extracted from supernatants containing 1 mg total protein for col-
lagen I and 5 mg for collagen III detection were separated in 8% polyacrylamide gels and transferred onto 0.2 µm 
PVDF membranes (Roche) at 90 mA for 4 h on ice. After blocking with milk, membranes were incubated with 
primary antibody at 4 °C overnight (anti-collagen I: Abcam #ab34710 (1:5000); anti-collagen III: Abcam #ab7778 
(1:1000) or Santa Cruz #sc-514601(1:100)) and with secondary HRP-conjugated antibody (anti-rabbit: Jackson 
Immuno Research #711-036-152 (1:10000) or anti-mouse: Thermo Fisher Scientific #62-6820 (1:2000)) for 1 h at 
RT. Protein bands were detected with SuperSignal West Femto Maximum Sensitivity Substrate (Thermo Fisher 
Scientific) in the chemiluminescence imager Chemi-Smart 5000 (Peqlab Biotechnologie, Erlangen, Germany) 
with the software Chemi-Capt 5000 version 12.8 (Vilber Lourmat, Eberhardzell, Germany). Membranes with total 
protein lysates were stripped with ReBlot Plus Mild Antibody Stripping Solution (Merck Millipore, Darmstadt, 
Germany), subsequently incubated with anti-beta actin antibody (1:5000) overnight (Abcam #ab8227) and 
detected as described above. Quantification of band densities was performed with ImageJ 1.48 v (NIH, USA). 























Table 1. Primer sequences for qPCR.
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Caspase 3/7 activity assay (Apoptosis assay). Caspase 3/7 activity was analysed with the Apo-ONE 
Homogenous Caspase 3/7 Assay (Promega, Madison, WI, USA). 4 × 103 BMSC seeded in black 96-well plates 
with clear bottom (Falcon, Corning, NY, USA) were transfected with mimic/inhibitor/NT-miR or cultured in 
CM/NM. 96 h after mimic transfection or culture in CM and 72 h after inhibitor transfection and culture in CM, 
Apo-ONE Caspase-3/7 Reagent was added and fluorescence was measured 3–8 h later in a plate reader (Tecan 
GENios with Magellan 6; Tecan Group Ltd., Männedorf, Switzerland). Experiments were performed in triplicates. 
CM and BMSC of 8 different donors were used for each of the three experimental setups (n = 8).
BrdU incorporation assay (Proliferation assay). Cell proliferation was quantified with the colorimetric 
BrdU Cell Proliferation ELISA (Roche). 4 × 103 BMSC/96-well were transfected with mimic/NT-miR or cultured 
in CM/NM. 72 h later, BrdU labelling solution was added and cells were incubated for 24 h at 37 °C and 5% 
CO2. Following the manufacturer’s instructions, after adding stop solution absorbance at 450 nm was measured. 
Experiments were performed in triplicates. CM and BMSC of 6–8 different donors were used for each of the two 
experimental setups (n = 6–8).
Inhibition and Stimulation of miR-29b expression. BMSC micromass pellets were cultured in NM or 
CM supplemented with Complete Mini Protease Inhibitor Cocktail with and without EDTA (Roche) for 7 days to 
analyse if the upregulation of miR-29b could be prevented when proteases like matrix metalloproteases (MMP) 
are inhibited. BMSC of 6 different donors were used (n = 6).
To investigate the influence of different cytokines on miR-29b expression, BMSC micromass pellets were 
stimulated for 7 days with the following cytokines (all from Peprotech, Hamburg, Germany) in chondrogenic 
medium: IL-1β (1 ng/ml), IL-6 (5 ng/ml), IL-8 (10 ng/ml) and IFN-γ (1 ng/ml, 10 ng/ml and 50 ng/ml). BMSC of 
4–11 different donors were used (n = 4–11).
Statistical analysis. Statistical analyses and graphing were performed with GraphPad Prism version 6 
(GraphPad Software, San Diego, CA, USA). Results are expressed as box plots with median, the 25th and 75th 
percentiles and whiskers showing the largest and smallest values. Non-parametric Wilcoxon signed rank test for 
paired analysis was used to test for significant differences compared relative to control values of 0 or 100%. p val-
ues < 0.05 were considered as statistically significant and are listed in Supplementary Table S5. Significant outliers 
(α = 0.05) were determined with the Grubbs test.
Data availability statement. The datasets generated and analyzed during the current study are available 
from the corresponding author on reasonable request.
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